Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 456

1.

Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.

Zhou YM, Cao L, Li B, Zhang RX, Sui CJ, Yin ZF, Yang JM.

Ann Surg Oncol. 2012 May;19(5):1700-6. doi: 10.1245/s10434-011-1772-6. Epub 2011 May 17.

PMID:
21584833
2.

Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

Lee TK, Poon RT, Yuen AP, Ling MT, Kwok WK, Wang XH, Wong YC, Guan XY, Man K, Chau KL, Fan ST.

Clin Cancer Res. 2006 Sep 15;12(18):5369-76.

3.

miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.

Qiu G, Lin Y, Zhang H, Wu D.

Biochem Biophys Res Commun. 2015 Jul 31;463(3):315-21. doi: 10.1016/j.bbrc.2015.05.062. Epub 2015 May 27.

PMID:
26022123
4.

FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.

Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.

World J Gastroenterol. 2015 Jan 7;21(1):196-213. doi: 10.3748/wjg.v21.i1.196.

5.

MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.

Yokobori T, Suzuki S, Tanaka N, Inose T, Sohda M, Sano A, Sakai M, Nakajima M, Miyazaki T, Kato H, Kuwano H.

Cancer Sci. 2013 Jan;104(1):48-54. doi: 10.1111/cas.12030. Epub 2012 Nov 8.

6.

14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.

Liu TA, Jan YJ, Ko BS, Liang SM, Chen SC, Wang J, Hsu C, Wu YM, Liou JY.

PLoS One. 2013;8(3):e57968. doi: 10.1371/journal.pone.0057968. Epub 2013 Mar 6.

7.

Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition.

Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB, Shi GM, Ke AW, Yang XR, Tao ZH, Zhao YM, Qin Y, Zeng HY, Tang ZY, Fan J, Zhou J.

Clin Cancer Res. 2011 Dec 1;17(23):7294-302. doi: 10.1158/1078-0432.CCR-11-1327. Epub 2011 Oct 5.

8.

MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.

Feng XJ, Pan Q, Wang SM, Pan YC, Wang Q, Zhang HH, Zhu MH, Zhang SH.

Tumour Biol. 2016 Aug;37(8):11457-67. doi: 10.1007/s13277-016-5022-1. Epub 2016 Mar 24.

PMID:
27010469
9.

HOXD9 promotes epithelial-mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma.

Lv X, Li L, Lv L, Qu X, Jin S, Li K, Deng X, Cheng L, He H, Dong L.

J Exp Clin Cancer Res. 2015 Oct 29;34:133. doi: 10.1186/s13046-015-0245-3.

10.

BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma.

Xiao S, Liu L, Fang M, Zhou X, Peng X, Long J, Lu X.

Dig Dis Sci. 2015 Apr;60(4):910-8. doi: 10.1007/s10620-014-3411-0. Epub 2014 Nov 2.

PMID:
25362514
11.

Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.

Xiong H, Hong J, Du W, Lin YW, Ren LL, Wang YC, Su WY, Wang JL, Cui Y, Wang ZH, Fang JY.

J Biol Chem. 2012 Feb 17;287(8):5819-32. doi: 10.1074/jbc.M111.295964. Epub 2011 Dec 28.

12.

Knockdown of thrombomodulin enhances HCC cell migration through increase of ZEB1 and decrease of E-cadherin gene expression.

Huang MT, Wei PL, Liu JJ, Liu DZ, Huey-Chun H, An J, Wu CC, Wu CH, Ho YS, Yang YY, Chang YJ.

Ann Surg Oncol. 2010 Dec;17(12):3379-85. doi: 10.1245/s10434-010-1163-4. Epub 2010 Jul 13.

PMID:
20625840
13.

ZEB1 promotes epithelial-mesenchymal transition in cervical cancer metastasis.

Ran J, Lin DL, Wu RF, Chen QH, Huang HP, Qiu NX, Quan S.

Fertil Steril. 2015 Jun;103(6):1606-14.e1-2. doi: 10.1016/j.fertnstert.2015.03.016. Epub 2015 May 8.

PMID:
25963537
14.

Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma.

Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC.

Hepatology. 2009 Nov;50(5):1464-74. doi: 10.1002/hep.23221.

PMID:
19821482
15.

FBW7 increases chemosensitivity in hepatocellular carcinoma cells through suppression of epithelial-mesenchymal transition.

Yu J, Zhang W, Gao F, Liu YX, Chen ZY, Cheng LY, Xie SF, Zheng SS.

Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):184-91.

PMID:
24686546
16.

Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma.

Li T, Xie J, Shen C, Cheng D, Shi Y, Wu Z, Deng X, Chen H, Shen B, Peng C, Li H, Zhan Q, Zhu Z.

Oncogene. 2016 Mar 24;35(12):1575-84. doi: 10.1038/onc.2015.223. Epub 2015 Jun 15.

PMID:
26073087
17.

Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma.

Du R, Wu S, Lv X, Fang H, Wu S, Kang J.

J Exp Clin Cancer Res. 2014 Dec 14;33:105. doi: 10.1186/s13046-014-0105-6.

18.

Loss of MicroRNA-101 Promotes Epithelial to Mesenchymal Transition in Hepatocytes.

Zhao S, Zhang Y, Zheng X, Tu X, Li H, Chen J, Zang Y, Zhang J.

J Cell Physiol. 2015 Nov;230(11):2706-17. doi: 10.1002/jcp.24995.

PMID:
25808945
19.

Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.

Yamada S, Okumura N, Wei L, Fuchs BC, Fujii T, Sugimoto H, Nomoto S, Takeda S, Tanabe KK, Kodera Y.

Ann Surg Oncol. 2014 Nov;21(12):3882-90. doi: 10.1245/s10434-014-3779-2. Epub 2014 May 15.

PMID:
24833103
20.

ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.

Singh M, Spoelstra NS, Jean A, Howe E, Torkko KC, Clark HR, Darling DS, Shroyer KR, Horwitz KB, Broaddus RR, Richer JK.

Mod Pathol. 2008 Jul;21(7):912-23. doi: 10.1038/modpathol.2008.82. Epub 2008 May 16.

Supplemental Content

Support Center